Mediclinic International PLC (LON:MDC) had its price objective reduced by Jefferies Group from GBX 833 ($10.87) to GBX 812 ($10.60) in a report issued on Wednesday morning. They currently have a hold rating on the stock.

A number of other research analysts have also weighed in on MDC. JPMorgan Chase & Co. reaffirmed a neutral rating and set a GBX 1,160 ($15.14) price objective on shares of Mediclinic International PLC in a report on Tuesday, August 23rd. Citigroup Inc. raised Mediclinic International PLC to a buy rating and upped their price objective for the stock from GBX 990 ($12.92) to GBX 1,150 ($15.01) in a report on Tuesday, June 28th. Seven equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Mediclinic International PLC presently has a consensus rating of Hold and a consensus target price of GBX 964.43 ($12.59).

Mediclinic International PLC (LON:MDC) traded down 0.58% on Wednesday, hitting GBX 936.00. The stock had a trading volume of 758,948 shares. The stock’s 50 day moving average is GBX 1,011.19 and its 200 day moving average is GBX 961.58. The stock’s market cap is GBX 6.90 billion. Mediclinic International PLC has a one year low of GBX 794.50 and a one year high of GBX 1,219.00.

About Mediclinic International PLC

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.

Receive News & Stock Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related stocks with our FREE daily email newsletter.